Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP759819.RA0ukbQkJoaVPNfmfdr7qxPNl_rg7o2vFbWyOwj2JHdVQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP759819.RA0ukbQkJoaVPNfmfdr7qxPNl_rg7o2vFbWyOwj2JHdVQ130_assertion type Assertion NP759819.RA0ukbQkJoaVPNfmfdr7qxPNl_rg7o2vFbWyOwj2JHdVQ130_head.
- NP759819.RA0ukbQkJoaVPNfmfdr7qxPNl_rg7o2vFbWyOwj2JHdVQ130_assertion description "[We document robust FoxO activation in Tsc1-deficient benign polycystic kidneys and FoxO extinction on progression to murine renal tumors; murine renal tumor progression on genetic deletion of both Tsc1 and FoxOs; and downregulated FoxO expression in most human renal clear cell and papillary carcinomas, yet continued expression in less aggressive RCCs and benign renal tumor subtypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP759819.RA0ukbQkJoaVPNfmfdr7qxPNl_rg7o2vFbWyOwj2JHdVQ130_provenance.
- NP759819.RA0ukbQkJoaVPNfmfdr7qxPNl_rg7o2vFbWyOwj2JHdVQ130_assertion evidence source_evidence_literature NP759819.RA0ukbQkJoaVPNfmfdr7qxPNl_rg7o2vFbWyOwj2JHdVQ130_provenance.
- NP759819.RA0ukbQkJoaVPNfmfdr7qxPNl_rg7o2vFbWyOwj2JHdVQ130_assertion SIO_000772 21075312 NP759819.RA0ukbQkJoaVPNfmfdr7qxPNl_rg7o2vFbWyOwj2JHdVQ130_provenance.
- NP759819.RA0ukbQkJoaVPNfmfdr7qxPNl_rg7o2vFbWyOwj2JHdVQ130_assertion wasDerivedFrom befree-20150227 NP759819.RA0ukbQkJoaVPNfmfdr7qxPNl_rg7o2vFbWyOwj2JHdVQ130_provenance.
- NP759819.RA0ukbQkJoaVPNfmfdr7qxPNl_rg7o2vFbWyOwj2JHdVQ130_assertion wasGeneratedBy ECO_0000203 NP759819.RA0ukbQkJoaVPNfmfdr7qxPNl_rg7o2vFbWyOwj2JHdVQ130_provenance.